Advisor Group’s NeoGenomics NEO Stock Holding History

Advisor Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.94M	Buy	66,206 +63,494	+2,341%	+$1.51M	0.01%	833
2019 Q3	$53K	Sell	2,712 -52,749	-95%	-$1.24M	﹤0.01%	3358
2019 Q2	$1.22M	Buy	55,461 +52,062	+1,532%	+$1.14M	0.01%	1006
2019 Q1	$69K	Buy	3,399 +1,973	+138%	+$34.3K	﹤0.01%	3155
2018 Q4	$18K	Buy	1,426 +153	+12%	+$2.28K	﹤0.01%	3879
2018 Q3	$19K	Sell	1,273 -11	-0.9%	-$152	﹤0.01%	3931
2018 Q2	$17K	Sell	1,284 -5	-0.4%	-$55	﹤0.01%	3807
2018 Q1	$10K	Hold	1,289	–	–	﹤0.01%	4080
2017 Q4	$12K	Sell	1,289 -2,625	-67%	-$24.2K	﹤0.01%	3991
2017 Q3	$44K	Buy	3,914 +380	+11%	+$3.7K	﹤0.01%	3037
2017 Q2	$32K	Buy	+3,534	New	+$28K	﹤0.01%	3157

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Advisor Group's NEO Position: Q4 2019 in Review

Advisor Group increased its NeoGenomics (NEO) stake by 2,341% in Q4 2019, buying an estimated $1.51M and bringing the position to 66,206 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #833.

Advisor Group first reported a position in NEO in Q2 2017 and has held it in 11 quarters since. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

Advisor Group held 66,206 shares of NeoGenomics worth $1.94M as of Q4 2019.
Advisor Group bought 63,494 NeoGenomics shares in Q4 2019, an estimated $1.51M.
NeoGenomics made up 0.01% of Advisor Group's portfolio in Q4 2019, its #833 holding.
Advisor Group first reported a position in NeoGenomics in Q2 2017 and has held it in 11 quarters since.
261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.